Navigation Links
LightLab Imaging Introduces World's Highest Resolution OCT System for Intracoronary Imaging at EuroPCR 2009
Date:5/13/2009

Launch of C7XR(TM) FD-OCT Imaging System and Companion C7 Dragonfly(TM) Imaging Catheter Strengthen LightLab's Market Leadership

WESTFORD, Mass., May 14 /PRNewswire/ -- LightLab Imaging Inc., the pioneer and leader in the development of Optical Coherence Tomography (OCT) for vascular and other applications, today announced the launch of its next-generation system, the C7XR FD-OCT Imaging System with the C7 Dragonfly Imaging Catheter, at EuroPCR 2009, Barcelona, Spain, solidifying the company's leadership in the intracoronary OCT imaging product market.

The C7XR FD-OCT Imaging System is the world's first approved Frequency Domain OCT product for intracoronary imaging, having received CE Mark in March 2009. The C7XR FD-OCT Imaging System and C7 Dragonfly Imaging Catheter enables micron level resolution imaging of the coronary artery with the capability to scan a 40mm artery segment in less than 3 seconds with a single non-occlusive catheter.

Dr Francesco Prati, Ospedale San Giovanni, Rome commented, "The C7XR system and C7 Dragonfly imaging catheter represent a significant step forward for intracoronary imaging. I am very pleased with the speed and simplicity of the imaging procedure and the improvements in image quality are truly impressive. I would expect frequency domain OCT to replace IVUS in many cases or centers."

"The launch of the C7XR Imaging System and Dragonfly Catheter is an important milestone for LightLab Imaging, and represents years of successful collaboration with many of the world's leading interventionalists," said David Kolstad, President and CEO of LightLab Imaging. "The image quality is extraordinary, greatly enhancing ease of image interpretation. We are confident that it will quickly improve best practices for stent procedures and other intracoronary interventions."

About LightLab OCT

OCT generates intravascular images with a resolution up to 10 to 15 times greater than other clinically available imaging devices, including Intravascular Ultrasound (IVUS). With its higher resolution, OCT may reduce observer variability in all standard cross-sectional measurements.

The C7XR system follows the M2x OCT Imaging System, LightLab's Time Domain OCT (TD-OCT) device, which is available in more than 20 countries worldwide. More than 10,000 patient intracoronary images have been taken since the company launched the M2x which, until the launch of the C7XR FD-OCT Imaging System, was the only commercially available intracoronary OCT imaging device in the world.

The C7XR system further advances LightLab's product offering by providing a system that is 10 times faster, and of even higher resolution. These advances permit high speed, non-occlusive imaging of coronary vasculature at extremely high resolution. A single catheter design obtains images of the coronary anatomy with extraordinary image quality in mere seconds.

About LightLab ImagingInc.

LightLab Imaging Inc. is the pioneer and leader in the development of Optical Coherence Tomography (OCT) for vascular and other applications. With a proprietary platform and catheter technologies protected by over 50 patents, OCT is a high-resolution imaging modality that applies advanced photonics to medical imaging. With the ability to resolve real-time images to 15 micrometers, the LightLab Imaging OCT Imaging Systems offer physicians more information, and more precise information, than ever before available. LightLab's products are presently not available for sale in the United States.


'/>"/>
SOURCE LightLab Imaging Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Axsun Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab Imaging
2. Ziehm Imaging and BrainLAB Extend Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS) to North America
3. PreXion Adds High-resolution Panoramic Imaging
4. VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque
5. IMRIS receives CE Mark approval for interventional imaging system
6. The Ohio State University, Cardinal Health, State of Ohio to Invest $10 Million to Advance Medical Imaging Industry
7. Imaging IDs Brain Neurons With Preference for Real Words
8. Further Testing With Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer in Breast Cancer Patients, Changes Surgical Management
9. MDS Analytical Technologies Releases MetaXpressPowerCore(TM) and MetaXpress(R) 3.0 Cellular Imaging Software
10. MRI: Imaging technique of choice to exam pregnant patients with possible appendicitis
11. Educating referring clinicians about advanced imaging leads to drop in imaging exams
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 25, 2017 , ... Back Pain Centers of America (BPC), which ... physician in their area, announces the launch of a new and proprietary customer relationship ... looking for reputable physicians to help them with back or neck pain and helps ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS Healthcare ... Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. , ... medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for patients. ...
(Date:4/24/2017)... ... 24, 2017 , ... Ridgecrest Herbals makes it a point to lead the ... waste, and support renewable energy. They believe this is a crucial part of their ... for health issues, and maintain that destroying the environment in the pursuit of profit ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
Breaking Medicine Technology: